- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial
- Study type descriptors: Interventional
- Study aim: To evaluate the therapeutic efficacy of immunoadsorption in treating post-COVID syndrome, particularly chronic fatigue, through a randomized, sham-controlled trial. Additionally, the study seeks to provide insights into the pathogenesis of post-COVID syndrome by investigating the role of autoantibodies and immune dysregulation in its development
- Number of participants enrolled: Enrollment ongoing
- Study enrolling from to
- Study includes follow-up for 3 months
Study Data
- Adults
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Immunoadsorption
External Links
Other information
Funders:
- Hannover Medical School
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to